betaxolol has been researched along with Eye Disorders in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Betaxolol is a lipophilic beta-adrenoceptor antagonist relatively selective for beta 1-adrenoceptors with only weak beta 2-blocking activity." | 6.38 | Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension. ( Buckley, MM; Clissold, SP; Goa, KL, 1990) |
| "Betaxolol is a relatively cardioselective β-adrenoceptor blocking drug, with no partial agonist (intrinsic sympathomimetic) activity and weak membrane-stabilizing (local anesthetic) activity." | 2.72 | Betaxolol: A comprehensive profile. ( Abdel-Aziz, AA; Al-Wadei, MJ; Bakheit, AH; Wani, TA, 2021) |
| "Betaxolol is a lipophilic beta-adrenoceptor antagonist relatively selective for beta 1-adrenoceptors with only weak beta 2-blocking activity." | 2.38 | Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension. ( Buckley, MM; Clissold, SP; Goa, KL, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Wadei, MJ | 1 |
| Bakheit, AH | 1 |
| Abdel-Aziz, AA | 1 |
| Wani, TA | 1 |
| Buckley, MM | 1 |
| Goa, KL | 1 |
| Clissold, SP | 1 |
2 reviews available for betaxolol and Eye Disorders
| Article | Year |
|---|---|
Betaxolol: A comprehensive profile.
Topics: Adrenergic beta-Antagonists; Betaxolol; Blood Pressure; Eye Diseases; Heart; Humans; Intraocular Pre | 2021 |
Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension.
Topics: Betaxolol; Eye Diseases; Glaucoma; Humans; Intraocular Pressure; Ophthalmic Solutions | 1990 |